Becton, Dickinson and Co. | BDX - Market Capitalization


Becton, Dickinson and Co. reported $57.62B in Market Capitalization this October of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Abbott USD 174.33B 3.32B Oct/2026
Agilent USD 39.08B 6.43B Jun/2026
Align Technology USD 12.08B 198M Jun/2026
AngioDynamics USD 511M 94M Sep/2025
Baxter International USD 11.01B 2.34B Jun/2026
Becton, Dickinson and Co. USD 41.7B 3.07B Jun/2026
Bio-Rad Laboratories USD 7.87B 390M Jun/2026
Boston Scientific USD 63.44B 29.82B Jun/2026
Cooper Companies USD 14.1B 1.83B Jun/2026
Danaher USD 168.91B 11.1B Oct/2026
Dentsply International USD 2.13B 191M Jun/2026
Dexcom USD 30.59B 4.6B Oct/2026
Edwards Lifesciences USD 52.09B 5.92B Jun/2026
Globus Medical USD 10.73B 963M Jun/2026
Insulet USD 10.55B 3.99B Jun/2026
Integra LifeSciences USD 926M 340M Oct/2026
Intuitive Surgical USD 155.25B 11.6B Oct/2026
J&J USD 607B 46.61B Oct/2026
Medtronic USD 109.3B 2.33B Jun/2026
Stryker USD 120.7B 5.15B Jun/2026
Tandem Diabetes Care USD 1.03B 276M Jun/2026
Teleflex USD 6.43B 815M Oct/2026
Terumo JPY 3.31T 186.55B Jun/2026
Thermo Fisher Scientific USD 264.64B 15.06B Oct/2026
WK Kellogg Co USD 13.36B 2.04B Jun/2026
Zimmer Biomet Holdings USD 16.66B 845M Jun/2026